The recent (June 2021) Webinar run by US Business Development...

The recent (June 2021) Webinar run by US Business Development Director Chris Ramsey (who spent 9 years at Beckman Coulter) has become available on the CCS website and their Linkedin.

Points of interest and quoting the presentation:

• "MRSA is in the hands of the FDA, and we will hear from them any day"
• Rapid AST capability (through AMR Module) - APAS can recognise and read 6 hour cultures, shrinking the normal 18 hour incubation to 6 hours - CLSI (Clinical & Laboratory Standards Institute) and EUCAST (European Committee on Antimicrobial Susceptibility Testing) rules supported.

Expecting we'll see the US Distribution Agreement on the back of FDA approval.